Evidence map›Paper›PMID 19476346›Full record

ArticleBiochemistry2009

Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Zhuji Fu, Chen Chen, Joseph T Barbieri, Jung-Ja P Kim, Michael R Baldwin

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhuji FuDepartment of Biochemistry, Medical Collegeof Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, USA.
Chen Chen
Joseph T Barbieri
Jung-Ja P Kim
Michael R Baldwin
Medical College of Wisconsin · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SCHLESINGER, LARRY S. · 2003 to 2013
$87.6M
Interaction of Botulinum neurotoxins with presynaptic receptor complexesR00NS061763 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI BALDWIN, MICHAEL R · 2009 to 2011
$739k
Interaction of Botulinum neurotoxins with presynaptic receptor complexesK99NS061763 · NINDS · MEDICAL COLLEGE OF WISCONSIN · PI BALDWIN, MICHAEL R · 2007 to 2008
$166k
NIAID NIH HHS U54 AI057153NINDS NIH HHS K99 NS061763NINDS NIH HHS R00 NS061763
6 · The paper itself

Abstract

Botulinum neurotoxin causes rapid flaccid paralysis through the inhibition of acetylcholine release at the neuromuscular junction. The seven BoNT serotypes (A-G) have been proposed to bind motor neurons via ganglioside-protein dual receptors. To date, the structure-function properties of BoNT/F host receptor interactions have not been resolved. Here, we report the crystal structures of the receptor binding domains (HCR) of BoNT/A and BoNT/F and the characterization of the dual receptors for BoNT/F. The overall polypeptide fold of HCR/A is essentially identical to the receptor binding domain of the BoNT/A holotoxin, and the structure of HCR/F is very similar to that of HCR/A, except for two regions implicated in neuronal binding. Solid phase array analysis identified two HCR/F binding glycans: ganglioside GD1a and oligosaccharides containing an N-acetyllactosamine core. Using affinity chromatography, HCR/F bound native synaptic vesicle glycoproteins as part of a protein complex. Deglycosylation of glycoproteins using alpha(1-3,4)-fucosidase, endo-beta-galactosidase, and PNGase F disrupted the interaction with HCR/F, while the binding of HCR/B to its cognate receptor, synaptotagmin I, was unaffected. These data indicate that the HCR/F binds synaptic vesicle glycoproteins through the keratan sulfate moiety of SV2. The interaction of HCR/F with gangliosides was also investigated. HCR/F bound specifically to gangliosides that contain alpha2,3-linked sialic acid on the terminal galactose of a neutral saccharide core (binding order GT1b = GD1a >> GM3; no binding to GD1b and GM1a). Mutations within the putative ganglioside binding pocket of HCR/F decreased binding to gangliosides, synaptic vesicle protein complexes, and primary rat hippocampal neurons. Thus, BoNT/F neuronal discrimination involves the recognition of ganglioside and protein (glycosylated SV2) carbohydrate moieties, providing a structural basis for the high affinity and specificity of BoNT/F for neurons.

Indexed as

AnimalsBinding SitesBotulinum ToxinsBotulinum Toxins, Type AGangliosidesGlycosylationMembrane GlycoproteinsModels, MolecularNerve Tissue ProteinsNeuronsProtein ConformationRatsRats, Sprague-DawleySynaptic VesiclesBotulinum ToxinsBotulinum Toxins, Type Abotulinum toxin type FGangliosidesMembrane GlycoproteinsNerve Tissue ProteinsSv2a protein, rat

Identifiers

PMID19476346
PMCPMC2709598
OpenAlexW2033701533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.